# MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5
> **ANDA215370** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2022-06-29
## Drug
- **FDA Application Number:** ANDA215370
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5
- **Generic name:** SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE
- **Active ingredients:** MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2022-06-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215370)
---
*AI Analytics · CC0 1.0*